Real-time enrollment status for this cirrhosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:07 PM UTC
| NCT Number | NCT06528314 |
| Recruiting Status | Recruiting |
| Condition | Cirrhosis |
| Phase | Clinical Trial |
| Target Enrollment | 1,150 participants |
| Active Locations | 150 sites in the US |
| Sponsor | Akero Therapeutics, Inc |
| Last Updated on CT.gov | February 19, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT06528314 is currently recruiting participants. This clinical trial study for cirrhosis is actively seeking new participants at 150 locations across the United States. The study is sponsored by Akero Therapeutics, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06528314 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 150 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06528314 was last updated 1 week ago (February 19, 2026). HelloStudys verifies this status automatically.